BCLI: Brainstorm Cell Therapeutics Inc. Stock

by  •  • Comments Off on BCLI: Brainstorm Cell Therapeutics Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 5.19
Enterprise Value ($M) 5.30
Book Value ($M) -7.76
Book Value / Share -1.19
Price / Book -0.67
NCAV ($M) -9.21
NCAV / Share -1.41
Price / NCAV -0.56

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -3.47
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.04
Current Ratio 0.04

Balance Sheet (mrq) ($M)
Current Assets 0.39
Assets 1.83
Liabilities 9.60
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -11.69
Net Income -11.62

Cash Flow Statement (mra) ($M)
Cash From Operations -9.09
Cash from Investing 0.01
Cash from Financing 7.97

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Armistice Capital, Llc 4.99 -96.29
11-13 13G Ruck Matthew J 5.18

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-31 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ⌧ ANNUAL REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2024 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 22,316 47,565 46.92
2025-04-16 23,548 106,547 22.10
2025-04-15 22,479 64,083 35.08
2025-04-14 3,731 39,247 9.51

(click for more detail)

Similar Companies
AVTX – Avalo Therapeutics, Inc. AYTU – Aytu BioPharma, Inc.
BCDA – BioCardia, Inc. BCTX – BriaCell Therapeutics Corp.
BFRG – Bullfrog AI Holdings, Inc.


Financial data and stock pages provided by
Fintel.io